Concepedia

David S. Wells

DS

Statistics

Publications

11

Citations

583

H-Index

10

Active since

1983

Affiliations

Arrien Pharmaceuticals (United States)(Current)

North Carolina State University

Concert Pharmaceuticals (United States)

David S. Wells is an author at Arrien Pharmaceuticals (United States) specializing in medicine, pharmacology, and life sciences.

Publications per year

1983–2015

11

Publications

11

Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats

Jacquelin Jolette, Clynn E. Wilker, Susan Y. Smith et al. · Toxicologic Pathology · 2006 · 142 citations

, , +16

Perceptual grouping in schizophrenia: Replication of Place and Gilmore.

David S. Wells, Donald Leventhal · Journal of Abnormal Psychology · 1984 · 85 citations

, , +12

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

Jean‐Francois Marier, Martin Béliveau, Samer Mouksassi et al. · The Journal of Clinical Pharmacology · 2008 · 77 citations

, , +9

Perceptual grouping in schizophrenia: Replication of Place and Gilmore.

David S. Wells, Donald Leventhal · Journal of Abnormal Psychology · 1984 · 63 citations

, , +12

Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine

Vinita Uttamsingh, Richard Gallegos, Julie F. Liu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 58 citations

, , +17

1–5 of 11